Helsinki-based healthtech company Gosta Labs has closed a €7.5 million seed round to scale its AI operating system for complex medical specialities. The round was led by Voima Ventures, with participation from COR Group, the Aho family, and both existing and new investors, including Reaktor and a group of notable angel investors. This follows a €1.7 million pre-seed round in 2024 and brings the company’s total funding to nearly €10 million.
Cancer care is becoming increasingly complex. According to recent studies, by 2050, more than 35 million new cancer cases are projected across over 100 cancer types. At the same time, clinicians spend several hours per day on administrative tasks in fragmented systems with largely unstructured clinical data, and multidisciplinary teams must make rapid, high-stakes decisions across a growing range of personalized treatment options.
Gosta Labs addresses these challenges with an oncology-focused AI operating system that converts each patient visit into high-quality structured data in real time. The system summarises and visualises patient journeys, automates clinical documentation, and captures structured clinical data relevant to patient care.
It also supports quality of care by assessing key clinical parameters for each treatment pathway and automatically linking decisions to international guidelines. This helps oncologists deliver faster and more consistent care.
The first real-world results from the Gosta AI Operating System were presented at the ESMO 2025 Congress. The findings indicate that the system generates high-quality consultation notes in real time, structured according to institutional standards. It also automatically classifies Performance Status and CTCAE toxicity grades. Oncologists were able to complete follow-up visit documentation in a median time of under two minutes, reducing documentation workload and allowing more time for direct patient care.
Founded in 2023 by Lauri Sippola and Henri Viertolahti, the founders of Kaiku Health (acquired by Elekta in 2020), Gosta Labs builds on a track record of developing and scaling regulated digital health solutions globally. The team combines AI specialists with experienced oncology and medtech leaders, including Chief Medical Officer Dr Lionel Hadjadjeba and Chief Operating Officer Reetta Arokoski, both of whom have extensive experience in scaling cancer care technologies internationally.
The new funding will be used to expand the reach of its AI assistant to oncology teams globally and to further strengthen Gosta Labs’ medical-device-grade product and AI foundation, enabling safer, more personalised patient encounters with reduced administrative burden.
Would you like to write the first comment?
Login to post comments